Vonrhein, C
The formulation contains: Retatrutide A research peptide currently being investigated for its interaction with GLP-1, GIP, and glucagon receptor pathways
Muscle: 250 to 500 mcg once or twice daily, subcutaneous near the muscle, 4 to 8 weeks
Since mitochondria are essential for maintaining intracellular calcium levels, disruptions in calcium uptake via the mitochondrial calcium uniporter (MCU) have been associated with reduced ATP production, and impaired MMP, both of which we see in the BD COs, further supporting future studies of mitochondrial calcium in BD [75, 76]
Of particular promise, nanoparticles can insulate their contents from external biochemical injury [11]
Could be a lower-purity analog or misidentified compound